Northwire Canada EditionWednesday, July 15, 2026
Sign inSubscribe
Northwire
⌕
EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0%

Healthcare

Page 59
  1. Feb 18, 2026 · 19:01 · RVX

    Resverlogix Closes $2.8 Million Shares-for-Interest Private Placement

    Resverlogix Closes $2.8 Million Shares-for-Interest Private Placement

    01
  2. Feb 18, 2026 · 18:51 · MBIO

    Mindbio develops Edge AI for voice intoxication checks

    Mindbio develops Edge AI for voice intoxication checks

    02
  3. Feb 18, 2026 · 17:46 · GUD

    Knight seeks Brazilian regulatory okay for Niktimvo

    Knight seeks Brazilian regulatory okay for Niktimvo

    03
  4. Feb 18, 2026 · 17:30 · BCT

    BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

    BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

    04
  5. Feb 18, 2026 · 17:10 · TELO

    Telo Genomics closes first tranche for $840,000

    Telo Genomics closes first tranche for $840,000

    05
  6. Feb 18, 2026 · 16:50 · NVRS

    Noveris Provides Supplemental Disclosure Regarding Previously Announced Convertible Debenture Issuances

    Noveris Provides Supplemental Disclosure Regarding Previously Announced Convertible Debenture Issuances

    06
  7. Feb 18, 2026 · 16:16 · VST

    Victory Square Provides Corporate Update on Healthcare Infrastructure Strategy and Portfolio Developments

    Victory Square Provides Corporate Update on Healthcare Infrastructure Strategy and Portfolio Developments

    07
  8. Feb 18, 2026 · 16:05 · BHC

    BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

    BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

    08
  9. Feb 18, 2026 · 16:01 · EPRX

    Eupraxia Pharmaceuticals Announces Proposed Public Offering

    Eupraxia Pharmaceuticals Announces Proposed Public Offering

    09
  10. Feb 18, 2026 · 09:15 · MBIO

    MindBio Announces Private Placement to Raise up to $650,000

    MindBio Announces Private Placement to Raise up to $650,000

    10
  11. Feb 18, 2026 · 08:06 · MBIO

    MindBio Advances Large-Scale Deployment of Voice Intoxication Detection Through Integrated Edge AI Hardware-Software Platform

    MindBio Advances Large-Scale Deployment of Voice Intoxication Detection Through Integrated Edge AI Hardware-Software Platform

    11
  12. Feb 18, 2026 · 08:01 · IZO

    Izotropic Signs Letter Agreement for Regional Operations in Africa & the GCC

    Izotropic Signs Letter Agreement for Regional Operations in Africa & the GCC

    12
  13. Feb 18, 2026 · 08:01 · MRVL

    Marvel Biosciences Secures Funding to Develop Child-Friendly Liquid Formulation for Neurodevelopmental Disorders

    Marvel Biosciences Secures Funding to Develop Child-Friendly Liquid Formulation for Neurodevelopmental Disorders

    13
  14. Feb 18, 2026 · 07:31 · CHER

    Cheelcare Closes $1.0 Million Unsecured Note Financing

    Cheelcare Closes $1.0 Million Unsecured Note Financing

    14
← Newer Older →